Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
01/1998
01/29/1998WO1997036609A3 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
01/29/1998DE3745019C2 Cross-protective human monoclonal antibody compsns.
01/29/1998DE19632755C1 Monoclonal antibody specific for CDw109 cell surface protein
01/29/1998DE19630557A1 Gewebe-Transglutaminase (EC 2.3.13, tTG), in der Eigenschaft als Autoantigen der einheimischen Sprue/Zöliakie, welches spezifisch durch Antikörper aus Seren von Patienten mit einheimischer Sprue erkannt wird; Tissue transglutaminase (EC 2.3.13, tTG), in its capacity as autoantigen of celiac local / celiac disease, which is specifically recognized by antibodies from sera of patients with endemic sprue; deren Verwendung in Diagnostik, Therapiekontrolle und Therapie der Sprue, sowie anderer Erkrankungen/Symptome, die mit einer Immunreaktion gegen die tTG einhergehen their use in diagnosis, therapy monitoring and treatment of celiac disease, and other diseases / symptoms associated with an immune reaction against tTG
01/29/1998DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use
01/29/1998CA2262863A1 Antiviral linear polymers
01/29/1998CA2262008A1 Bivalent agonists for g-protein coupled receptors
01/29/1998CA2261898A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof
01/29/1998CA2261885A1 Substance p treatment for immunostimulation
01/29/1998CA2261797A1 Cyclic peptides having broad spectrum antimicrobial activity
01/29/1998CA2261570A1 Use of conantokins
01/29/1998CA2261568A1 Conantokins
01/29/1998CA2261013A1 Human kallikrein
01/29/1998CA2260767A1 Fas ligand-like protein, its production and use
01/29/1998CA2260763A1 Melatonin 1a receptor gene regulatory regions and uses thereof
01/29/1998CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
01/29/1998CA2236036A1 Signal-regulated, cleavage-mediated toxins
01/29/1998CA2232142A1 Cd6 ligand
01/28/1998EP0821066A1 Polypeptide of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptide
01/28/1998EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44)
01/28/1998EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations
01/28/1998EP0821007A2 Aprotinin variants with improved properties
01/28/1998EP0821006A2 Derivatives of insulin having enhanced zinc binding activity
01/28/1998EP0821004A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
01/28/1998EP0821003A1 Peptides and remedy for autoimmune diseases comprising the same
01/28/1998EP0820773A1 Treatment of diabetes with a glucokinase gene
01/28/1998EP0820515A1 Phospholipase c homolog
01/28/1998EP0820512A1 New chemokine expressed in eosinophils
01/28/1998EP0820511A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas
01/28/1998EP0820510A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
01/28/1998EP0820508A1 Dumbbell sense oligonucleotide for inhibiting herpes simplex virus (hsv)
01/28/1998EP0820507A1 Ndf peptides
01/28/1998EP0820472A1 Monoclonal antiidiotypic antibodies (ab2) and uses thereof
01/28/1998EP0820470A1 Novel anti-aids immunotoxins
01/28/1998EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands
01/28/1998EP0820467A1 Methods of treating disorders of the eye
01/28/1998EP0820464A2 Cysteine protease inhibitor
01/28/1998EP0820453A1 Thrombin inhibitors
01/28/1998EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
01/28/1998EP0820314A1 Autologous fibrin glue and methods for its preparation and use
01/28/1998EP0820311A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
01/28/1998EP0820310A1 Method for in vivo regulation of cardiac muscle contractility
01/28/1998EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
01/28/1998EP0820302A1 Combination compositions containing benazepril or benazeprilat and valsartan
01/28/1998EP0820300A1 Controlled release biodegradable nanoparticles containing insulin
01/28/1998EP0820299A1 Formulations for il-12
01/28/1998EP0820298A1 Peptide growth factor having epidermal inducing activity
01/28/1998EP0820297A1 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
01/28/1998EP0820296A1 Analogs of growth hormone-releasing factor
01/28/1998EP0820295A1 Modified lysine or arginine containing proteins and peptides
01/28/1998EP0820291A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
01/28/1998EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
01/28/1998EP0820285A1 Methods and compositions for lipidization of hydrophilic molecules
01/28/1998EP0820277A1 Powdered pharmaceutical formulations having improved dispersibility
01/28/1998EP0672679B1 Phospholipase c inhibiting peptide
01/28/1998EP0654046B1 Auto-cross-linked gellan gum
01/28/1998EP0422217B1 Human recombinant placental ribonuclease inhibitor and method of production
01/28/1998CN1171822A Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
01/28/1998CN1171816A CDNA encoding BMP type II receptor
01/28/1998CN1171815A Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from fusion product in aspergillus
01/28/1998CN1171792A Novel monoclonal antibody having inhibitory effect on type II phospholipase A2 and protein containing part of same
01/28/1998CN1171791A Purified thrombopoietin and method of making it
01/28/1998CN1171743A Novel tumor suppressor gene HIC-1
01/28/1998CN1171742A Selective acylation of epsilon-amino groups
01/28/1998CN1171268A Mixture containing SOD and VC for supplementing body energy
01/28/1998CN1171267A Clinical application of gamma-interferon in emergency contraception
01/28/1998CN1171248A Chinese medicine capsule for treating apoplexy
01/28/1998CN1037201C 多元溶剂清洗系统 Multiple solvent cleaning system
01/27/1998US5712417 Inhibitors of retroviral proteases
01/27/1998US5712397 Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
01/27/1998US5712395 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
01/27/1998US5712384 Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
01/27/1998US5712381 MADD, a TNF receptor death domain ligand protein
01/27/1998US5712380 Angiogenesis inhibitor
01/27/1998US5712375 Systematic evolution of ligands by exponential enrichment: tissue selex
01/27/1998US5712373 HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
01/27/1998US5712370 Erythropoietin (EPO) peptides and antibodies directed against these
01/27/1998US5712307 Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof
01/27/1998US5712291 Methods and compositions for inhibition of angiogenesis
01/27/1998US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
01/27/1998US5712265 Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders
01/27/1998US5712252 Keratin injection
01/27/1998US5712251 Treatment method
01/27/1998US5712250 Product for inhibition of human rotavirus infection
01/27/1998US5712249 Use of insulin-like growth factors I and II for inhibition of inflammatory response
01/27/1998US5712247 Use of lactoferrin to modulate and/or neutralize heparin activity
01/27/1998US5712245 Protection against infection
01/27/1998US5712160 From nerve growth factor receptor protein, applications to alzheimers*s disease and parkinson*s disease
01/27/1998US5712159 Glucose responsive insulin secreting β-cell lines and method for producing same
01/27/1998US5712155 DNA encoding tumor necrosis factor-α and -β receptors
01/27/1998US5712149 Chimeric receptor molecules for delivery of co-stimulatory signals
01/27/1998US5712148 Gamma-aminobutyric acid, vectors, plasmids
01/27/1998US5712145 Hepatitis C virus protease
01/27/1998US5712136 Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein
01/27/1998US5712122 Carboxy terminal peptide-extended proteins
01/27/1998US5712121 Treatment of illnesses with demonstrated eosinophilia
01/27/1998US5712120 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them
01/27/1998US5712118 Vaccine for branhamella catarrhalis
01/27/1998US5712117 Cytoplasmic antiproteinase-2 and coding sequences
01/27/1998US5712115 Polynucleotide encoding polypeptide with amino acid sequences